Opioid Withdrawal Syndrome Market Insights, Epidemiology, and Market Forecast 2034 Report

The market size of Opioid Withdrawal Syndrome is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as DemeRx IB, Inc., atai Life Sciences, MediciNova, BioXcel Therapeutics Inc., Elite Laboratories, Inc.

[Nevada, United States] - DelveInsight's "Opioid Withdrawal Syndrome Market Insights, Epidemiology, and Market Forecast 2034." report offers a detailed examination of Opioid Withdrawal Syndrome, covering historical and predicted epidemiology, market trends, and treatment scenarios in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.

To Know in detail about the Opioid Withdrawal Syndrome Market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; https://www.delveinsight.com/report-store/opioid-withdrawal-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Key Findings from the Opioid Withdrawal Syndrome Market Report:
The Opioid Withdrawal Syndrome market size is poised for significant growth, with an anticipated Compound Annual Growth Rate (CAGR) during the study period (2020-2034).
In August, 2024: atai Therapeutics, Inc. announced that their study DMX-IB 201 is a Phase 1/2a study of ibogaine consisting of an initial single ascending dose escalation stage to determine the maximum tolerated dose (MTD) or treat-to-target dose (TTD) in healthy volunteers, followed by a randomized, double-blind, placebo-controlled proof of concept stage to demonstrate the efficacy, safety and tolerability of the selected dose in opioid-dependent patients who seek medically supervised opioid withdrawal
In February, 2024: Proniras secured funding for Phase I withdrawal study. The investment will support the Phase I clinical study of PRN-001-01 (tezampanel), a new therapy for withdrawal.
In 2022, the total number of cases with long-term opioid usage was 9,077,124 in the 7MM, which is anticipated to decrease during the study period [2020-2034].
The analyzed Number of Opioid Misuse cases from the US population in 2022 was estimated to be approximately 85% of the 7MM. During the study period, the cases of opioid misuse in the US are expected to decrease at a CAGR of -1.8%.
DelveInsight estimates that the Number of Opioid Misuse cases in EU4 and the UK is expected to reach 1,051,533 by 2034 from 1,422,332 cases in 2022 during the forecast period (2024-2034) at a CAGR of -2.1%.
Key Opioid Withdrawal Syndrome Companies are as follows: DemeRx IB, Inc., atai Life Sciences, MediciNova, BioXcel Therapeutics Inc., Elite Laboratories, Inc.
Key Opioid Withdrawal Syndrome Therapies are as follow: Dexmedetomidine, Placebo, Lofexidine, DMX-1002, Lofexidine HCl, BXCL501, Oxycodone, Buprenorphine, MN-166.
Launching multiple stage Opioid Withdrawal Syndrome pipeline products is expected to revolutionize market dynamics, further propelling market growth.

Dive into our detailed Opioid Withdrawal Syndrome market research report to uncover actionable insights, industry forecasts, and competitive analysis @ https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Opioid Withdrawal Syndrome Overview:
Opioid withdrawal syndrome refers to a set of physical and psychological symptoms that occur when a person who has been using opioids regularly stops or reduces their intake suddenly. Opioids are a class of drugs that include both prescription medications like oxycodone, morphine, and codeine. Opioids bind to receptors in the brain and spinal cord, altering the way pain signals are perceived and producing feelings of euphoria.

Opioid Withdrawal Syndrome Drugs Uptake and Pipeline Development Activities:

The drugs uptake section examines the adoption rates of newly launched or anticipated drugs within the study period. It includes an analysis of market uptake by individual drugs, patient adoption by different therapies, and sales figures for each drug. The report also offers insights into Opioid Withdrawal Syndrome Pipeline Development Activities, evaluating therapeutic candidates at various stages of development and identifying key companies involved.

For more information about Opioid Withdrawal Syndrome companies working in the treatment market, visit https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Opioid Withdrawal Syndrome Therapies and Key Companies:
DMX-1002 (Ibogaine HCl): DemeRx IB, Inc./atai Life Sciences
MN-166: MediciNova
BXCL501, Dexmedetomidine: BioXcel Therapeutics Inc.
Lofexidine: USWM, LLC (dba US WorldMeds)
Oxycodone: Elite Laboratories, Inc

Opioid Withdrawal Syndrome Epidemiology:
The epidemiology section provides insights into historical, current, and forecasted trends in the seven major countries (7MM) from 2020 to 2034. It explores various studies and opinions to recognize the causes of current and forecasted trends. The segmentation includes total prevalence, severity-based prevalence, gender-specific prevalence, and diagnosed cases of episodic and chronic Opioid Withdrawal Syndrome.

Seize Market Opportunities with Our Expert Analysis! Our report delivers valuable insights into market dynamics, key players, and emerging trends @ https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Opioid Withdrawal Syndrome Epidemiology Segmentation:
The Opioid Withdrawal Syndrome market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
Opioid Withdrawal Syndrome Total Prevalence
Prevalent Cases of Opioid Withdrawal Syndrome by severity
Gender-specific Prevalence of Opioid Withdrawal Syndrome
Diagnosed Cases of Episodic and Chronic Opioid Withdrawal Syndrome

Opioid Withdrawal Syndrome Market Drivers and Barriers:
Globally, there is a growing recognition of the opioid crisis, which has raised awareness about opioid withdrawal syndrome and the need for effective treatments.
Pharmaceutical companies are investing in research and development aimed at creating more effective and safer treatments for opioid withdrawal, including medications and behavioral therapies.
The stigma surrounding opioid addiction and withdrawal persists, potentially dissuading individuals from pursuing treatment or utilizing the resources available to them.

Stay Ahead in a Competitive Landscape with Our Exhaustive Market Research Report-Dive Into Detailed Analysis, Key Trends, and Future Projections @ https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Scope of the Opioid Withdrawal Syndrome Market Report:
Study Period: 2020-2034
Coverage: 7MM (The United States, EU5, and Japan)
Key Opioid Withdrawal Syndrome Companies: [List of key companies]
Key Opioid Withdrawal Syndrome Therapies: [List of key therapies]
Opioid Withdrawal Syndrome Therapeutic Assessment: Current marketed and emerging therapies
Opioid Withdrawal Syndrome Market Dynamics: Opioid Withdrawal Syndrome Market drivers and Opioid Withdrawal Syndrome barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Opioid Withdrawal Syndrome Unmet Needs: Insights into unmet needs, KOL's views, Analyst's views, Market Access, and Reimbursement.

To access the full report and gain a deeper understanding of Opioid Withdrawal Syndrome market outlook, drug uptake, treatment scenario, and epidemiology trends: https://www.delveinsight.com/sample-request/opioid-withdrawal-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr

Table of Content
1. Key Insights
2. Report Introduction
3. Opioid Withdrawal Syndrome Market Overview at a Glance
4. Opioid Withdrawal Syndrome Epidemiology and Market Methodology
5. Executive Summary
6. Key Events
7. Opioid Withdrawal Syndrome: Disease Background and Overview
8. Opioid Withdrawal Syndrome Epidemiology and Patient Population
9. Patient Journey
10. Opioid Withdrawal Syndrome Marketed Drugs
11. Opioid Withdrawal Syndrome Emerging Drugs
12. Opioid Withdrawal Syndrome: Market Analysis
13. Key Opinion Leaders' Views
14. Opioid Withdrawal Syndrome SWOT Analysis
15. Opioid Withdrawal Syndrome Unmet Needs
16. Opioid Withdrawal Syndrome Market Access and Reimbursement
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer

List of Top Selling Market Research Reports in 2024

Surgical Energy Generators Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Surgical Sealant Tissue Patch Market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Surgical Stapling Devices Market- https://www.delveinsight.com/report-store/surgical-stapling-devices-market
Vital Sign Monitoring Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Pelvic Organ Prolapse Market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Scoliosis Market- https://www.delveinsight.com/report-store/scoliosis-market
SGLT2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Urinary Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Lymphedema Market- https://www.delveinsight.com/report-store/lymphedema-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Overactive Bladder Market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Facial Lines Market- https://www.delveinsight.com/report-store/facial-lines-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market

About DelveInsight:
DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry.

Contact Information:
Company Name: DelveInsight Business Research LLP
Contact Person: Ram Kapoor
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting

This release was published on openPR.